INFU

InfuSystem Holdings, Inc

NYSE· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001337013 Healthcare & Medical Devices

$14.13 +0.32 (+2.32%)

Oct 27 4:00 PM ET · prev $13.81

Market cap

$277.6M

Micro cap

Consensus

Buy

89% Buy or better · 9 analysts

Median target

$17.50

+24% · range $15.00–18.00

Next earnings

Nov 10

in 14 days · EPS est. $0.12

1 year

+35.2%

from $10.45 · Oct 28

30 days

+9.8%

from $12.87

52-week range

$7.42–14.23

−1% from high · low Feb 12

Avg volume 20D

112.5K

shares / day

Short interest

813.4K

≈4.1% of shares · −5.9%

Days to cover

7.6

at average volume

Insider net

+$150.4K

3 buyers · 0 sellers · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

SecBot read BULLISH 3 reports · 90 days

Balance 0 bearish · 1 bullish · 2 neutral oldest → newest, height = score

Avg score

·High conf. 1/3 ·Next Earnings date, Nov 10, 2026

Strongest BULLISH InfuSystem reported Q2 2026 net revenue of $36.9M (+2.6% YoY) and GAAP diluted EPS of $0.15, beating the…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

B Mar 2 1 insider buy $18.9K at $9.16
B May 8 to May 11 2 days of insider buys: $131.5K by 3 insiders, avg $8.76
R Aug 4 InfuSystem reported Q2 2026 net revenue of $36.9M (+2.6% YoY) and GA…

Signal stack

Where each data set points today.

InsidersBULLISH

3 insiders bought $150.4K at an average $8.81. No open-market sales. Price is 60% above their cost.
InstitutionsMIXED

Q2 2026: 10 added (0 new), 8 trimmed or exited.
AnalystsBULLISH

8 of 9 rate it Buy or better. Every target is above the price.
Short sellersSTEADY

Short interest −5.9% to 813.4K shares. 7.6 days to cover, ≈4.1% of shares.
TrendUPTREND

10% above its 50-day average.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
BlackRock, Inc.	DOUBLED	1,585,415	$15.3M
AMERICAN CENTURY COMPANIES INC	ADD	675,028	$6.5M
GEODE CAPITAL MANAGEMENT, LLC	DOUBLED	496,059	$4.8M
STATE STREET CORP	DOUBLED	212,571	$2.1M
PANAGORA ASSET MANAGEMENT INC	DOUBLED	194,922	$1.9M
NORTHERN TRUST CORP	DOUBLED	153,506	$1.5M
Bank of New York Mellon Corp	ADD	103,136	$995.3K
GOLDMAN SACHS GROUP INC	ADD	102,076	$985.0K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts

Buy 89% rate it Buy or better

Strong Buy3Buy5Hold1Sell0Strong Sell0

12-month targets · 3 analysts

$14.13 $15.00 $17.50 $18.00

Price is below the lowest target. Median implies +24%.Targets as of Oct 28, 2026.

Recent actions

Date	Firm	Action	Rating
Aug 5, 2026	B. Riley Securities REITERATE	REITERATE	Buy

Insider ledger

Form 4

$150.4K

bought · 3 insiders

sold · 0 insiders

+60.3%

vs their $8.81 cost

Date	Insider	Type	Value
Oct 9, 2026	Funke Jerod EVP-Chief HR Officer	EXERCISE	7,157 sh
Oct 9, 2026	Funke Jerod EVP-Chief HR Officer	TAX W/H	$28.5K
Sep 10, 2026	Shuda Scott Director	OTHER	20,000 sh
May 18, 2026	Steele Barry G Executive VP and CFO	TAX W/H	$33.8K
May 18, 2026	Chupa Addam Executive VP and CIO	EXERCISE	5,447 sh
May 18, 2026	Lachance Carrie President and CEO	TAX W/H	$31.3K
May 18, 2026	Chupa Addam Executive VP and CIO	TAX W/H	$17.7K
May 18, 2026	Steele Barry G Executive VP and CFO	EXERCISE	8,715 sh

Earnings setup

Estimates

Nov 10

reports in 14 days

$0.12

EPS estimate, this quarter

1↑ 0↓

revisions, 30 days

Current-quarter EPS estimate

$0.000

90d

$0.000

60d

$0.000

30d

$0.120

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	$0.12	$0.12–$0.12	—	$37.3M
Next Q	$0.14	$0.14–$0.14	—	$37.3M
Current FY	🔒 Fresh data, subscribers only
Next FY	🔒 Fresh data, subscribers only